Lymphocytic choriomeningitis virus 1 infection of the mouse central nervous system (CNS) elicits fatal immunopathology through blood-brain barrier breakdown 2 and convulsive seizures 3 . Although lymphocytic-choriomeningitis-virus-specific cytotoxic T lymphocytes (CTLs) are essential for disease 4 , their mechanism of action is not known. To gain insights into disease pathogenesis, we observed the dynamics of immune cells in the meninges by twophoton microscopy. Here we report visualization of motile CTLs and massive secondary recruitment of pathogenic monocytes and neutrophils that were required for vascular leakage and acute lethality. CTLs expressed multiple chemoattractants capable of recruiting myelomonocytic cells. We conclude that a CD8 1 T-cell-dependent disorder can proceed in the absence of direct T-cell effector mechanisms and rely instead on CTL-recruited myelomonocytic cells.
Lymphocytic choriomeningitis virus 1 infection of the mouse central nervous system (CNS) elicits fatal immunopathology through blood-brain barrier breakdown 2 and convulsive seizures 3 . Although lymphocytic-choriomeningitis-virus-specific cytotoxic T lymphocytes (CTLs) are essential for disease 4 , their mechanism of action is not known. To gain insights into disease pathogenesis, we observed the dynamics of immune cells in the meninges by twophoton microscopy. Here we report visualization of motile CTLs and massive secondary recruitment of pathogenic monocytes and neutrophils that were required for vascular leakage and acute lethality. CTLs expressed multiple chemoattractants capable of recruiting myelomonocytic cells. We conclude that a CD8 1 T-cell-dependent disorder can proceed in the absence of direct T-cell effector mechanisms and rely instead on CTL-recruited myelomonocytic cells.
To examine the dynamics of lymphocytic choriomeningitis virus (LCMV)-specific CTLs, we transferred 1 3 10 5 naive green fluorescent protein (GFP)-tagged T-cell receptor (TCR) transgenic CD8 1 T cells (GFP 1 P14 cells) into B6 mice one day before intracerebral (i.c.) inoculation with LCMV Armstrong. Naive CD8 1 T cells obtained from GFP 1 P14 transgenic mice express GFP under the b-actin promoter and express a TCR that recognizes the LCMV glycoprotein (amino acids [33] [34] [35] [36] [37] [38] [39] [40] [41] presented in H-2D b . Two-photon microscopy (TPM) was performed through a thinned skull window to visualize the meninges overlying the visual cortex in asymptomatic (day 5) and symptomatic (day 6) mice ( Fig. 1 and Supplementary Movie 1). In contrast to the few P14 cells observed on day 5 (Fig. 1a ), the number of GFP 1 P14 cells was notably increased in the meninges and perivascular regions on day 6 ( Fig. 1b, c) . To determine whether GFP 1 P14 cells were engaging in antigen-specific interactions, we analysed their motion in the presence of control antibody (immunoglobulin G, IgG) or a blocking monoclonal antibody to D b (anti-class I) introduced into the subarachnoid space through a small craniotomy ( Fig. 1d-i ). P14 speed averaged 3.41 6 0.27 mm min 21 (mean 6 s.e.m.) in the absence of the craniotomy and 3.04 6 0.33 mm min 21 in the presence of the craniotomy and IgG (Fig. 1j ). The anti-class I antibody significantly increased (*P , 0.0001) the speed of P14 cells to 5.16 6 0.46 mm min 21 (Fig. 1j, k) and decreased the arrest coefficient ( Fig. 1l ), but did not influence the speed of CTLs specific for an irrelevant antigen ( Supplementary Fig. 1 ). This significant change in P14 cell speed and arrest after anti-class I treatment was observed in all mice examined and did not depend on CTL abundance ( Supplementary Fig. 2 ). GFP 1 P14 CTL migration appeared random ( Supplementary Fig. 3 ), with confined motion at longer times that was reversed by anti-class I antibodies. Comparison of the speed distributions showed that the entire population shifts after anti-class I treatment ( Fig. 1k ), suggesting that all GFP 1 P14 cells encountered antigen. Despite this high frequency of antigen encounter, CTLs rarely synapsed with any one target for .10 min ( Fig. 1g, m) . These intravital observations raised questions about the infected target population and the CTL effector mechanisms used during fatal meningitis.
We identified the LCMV-infected cells through immunohistochemical studies ( Fig. 2, Supplementary Fig. 4 and Supplementary Movie 2). The main LCMV-infected population in the meninges and around meningeal vasculature was ER-TR7 1 stromal cells. LCMV infection was occasionally observed in CD45 1 infiltrating leukocytes and astrocytic foot processes that comprise the glial limitans ( Supplementary Fig. 4 ). Infection of endothelium, smooth muscle cells and pericytes was never observed ( Supplementary Fig. 4 ). ER-TR7 1 stromal cells support rapid migration of CD8 1 and CD4 1 T cells in lymph nodes 5 and may provide strong chemokinetic signals that can overwhelm synapse forming stop signals 6 . This might explain the paucity of antigen-specific arrest ( Fig. 1 ).
Because CD8 1 T cells are essential for pathology 4 , we evaluated several CTL effector mechanisms using genetic knockout and mutant mice ( Fig. 3a) . Surprisingly, mice with single deficiencies in all major CTL effector pathways-interferon-c receptor, tumour necrosis factora, Fas, granzymes, perforin and the degranulation pathway (Jinx, also known as Unc13d, mutant)-succumbed to the convulsive seizures observed after LCMV infection of wild-type mice. The delay in disease onset observed in perforin-knockout mice was recently attributed to slower CTL recruitment into the central nervous system (CNS) 7 . These data supported the imaging studies in suggesting that CTL effector functions might not be responsible for rapid-onset disease.
To investigate other effectors, we temporally examined the composition of the CNS infiltrate after i.c. LCMV infection ( Fig. 3b and Supplementary Fig. 5 ). Baseline populations prevailed until day 6, at which point monocytes and macrophages were massively recruited into the CNS. A low number of these cells preceded the arrival of CTLs by 2 days. At day 6 a small increase in the number of neutrophils, CD4 1 T cells and B cells was also observed; however, the latter two populations are not required for disease 8, 9 . It should be noted that our methodology accounts primarily for extravasated leukocytes, because cells arrested in the vasculature (for example, neutrophils) are expunged during intracardiac saline perfusions. Nevertheless, our results demonstrate a minimal innate cellular response to the virus alone and massive recruitment of myelomonocytic cells that coincided with the arrival of CTLs at day 6.
We next asked whether monocytes and/or neutrophils were required for the seizure-induced death on day 6 ( Fig. 3c-f ). Neutrophil depletion with low-dose anti-Gr-1 (also known as anti-Ly6g) antibody 10 (Fig. 3c, d ) or monocyte infiltration blockade using chemokine receptor 2 (CCR2)-deficient mice 11 (Fig. 3e , f) had no effect on the nature or kinetics of death. Therefore, we hypothesized that both populations might have the potential to induce CNS injury. To test this hypothesis, we depleted monocytes and neutrophils simultaneously by administering high-dose anti-Gr-1 to CCR2knockout mice (Fig. 3e , f). When both cell populations were depleted, seizure-induced death at day 6 was averted and survival was extended by 3 days (Fig. 3e, f) , despite a normal frequency of virus-specific CTLs on day 6 (data not shown). These data suggested that myelomonocytic cells were highly pathogenic and were responsible for the rapid-onset seizure-induced death observed at day 6.
During TPM analyses of GFP 1 P14 cells, we often noted that the vasculature appeared ragged and displayed plasma leakage tracked with intravascular-injected quantum dots ( Fig. 4a-d and Supplementary Movie 3). We considered that the seizure-induced death at day 6 might be induced by vascular leakage caused by myelomonocytic cells. To test this possibility, we conducted TPM in LCMV-infected lysozyme M (LysM)-GFP mice, in which neutrophils and monocytes were labelled with GFP, to detect the relationship between myelomonocytic extravasation and vascular leakage. There was a tight correlation between locally synchronized LysM-GFP 1 cell extravasation and vascular leakage on day 6 ( To determine the relative contribution of neutrophils versus monocytes to vascular injury, we imaged LysM-GFP mice injected with low-dose anti-Gr-1 antibody, which depletes only neutrophils ( Fig. 3c and Supplementary Fig. 6 ). Interestingly, synchronous extravasation of LysM-GFP 1 cells was not observed in low-dose Gr-1depleted mice ( Fig. 4i-l and Supplementary Movie 5), suggesting that synchronously extravasating LysM-GFP 1 cells are neutrophils.
In neutrophil-depleted LysM-GFP mice, we observed perivascular LysM-GFP 1 cells (that is, monocytes and macrophages) in areas of transient vascular leakage. Unlike neutrophils that display intravascular accumulation followed by explosive extravasation with vascular leakage, the monocytes accumulated more gradually in vascular sites that nonetheless displayed leakage. Statistically, sustained vascular leakage was only correlated (r 5 0.99; P , 0.0001) with neutrophils ( Fig. 4m ). The presence of intra-or extra-vascular P14 CTLs was not associated with either pattern of vascular leakage ( Fig. 4o ). Quantum dot leakage was not observed on day 5 post-infection ( Fig. 4p) , despite low numbers of infiltrating monocytes (Fig. 3b ). Vascular injury occurred only at day 6 post-infection and extended into the brain parenchyma ( Fig. 4q ). Myelomonocytic cells were restricted to the meninges on day 6 ( Fig. 4q, r and Supplementary  Fig. 10 ).
The impact of myelomonocytic cells on vascular injury was further assessed by quantifying leakage of Evans blue dye into the brain ( Supplementary Fig. 7 ). Only mice depleted of both monocytes and neutrophils showed significant (P , 0.001) preservation of vascular integrity at day 6 post-infection ( Supplementary Fig. 7e , f). Depletion of monocytes ( Supplementary Fig. 7d , f) or neutrophils ( Supplementary Fig. 7c , f) alone failed to prevent Evans blue leakage. Interestingly, in untreated wild-type mice at day 6 post-infection, we observed substantial leakage of Evans blue from meningeal blood vessels into the brain parenchyma ( Supplementary Fig. 8 ), reflecting disrupted blood-brain barrier (BBB) integrity, which has the potential to cause severe seizures 12 .
To examine a potential mechanism by which CTLs attract myelomonocytic cells, we used gene arrays to quantify differentially regulated transcripts in the brains of mock-versus day 6 LCMV-infected mice. Our results revealed a statistically significant increase (P , 0.05) in six chemokines (CCL2, 7.3-fold; CCL3, 8.1-fold; CCL4, 1.6-fold; CCL5, 5.6-fold; CCL7, 4.2-fold; CXCL2, 2.8-fold) and two chemokine receptors (CCR1, 2.6-fold; CCR2, 3.6-fold) that can recruit myelomonocytic cells into the CNS. Because it was reported that none of these chemokines were observed in the CNS of T-cell-deficient mice infected i.c. with LCMV 13 , we next used flow cytometry to examine which of these chemokines were produced by virus-specific P14 cells ( Supplementary Fig. 9 ). Our flow cytometric analyses of CNS and splenic P14 CTLs at day 6 revealed that CCL3, CCL4 and CCL5 were all produced at the protein level, which was confirmed using gene arrays 14, 15 . Both CCL3 and CCL4 required GP [33] [34] [35] [36] [37] [38] [39] [40] [41] peptide stimulation for maximum synthesis, whereas CCL5 was produced on differentiation from naive to effector cells and was not further upregulated on peptide stimulation.
It is well known that CD8 1 T cells are required for LCMV-induced meningitis 4 and vascular leakage 16 . Our results revealed that P14 CTLs produce three of the chemokines with the potential to attract the myelomonocytic cells responsible for vascular injury ( Fig. 4 and Supplementary Fig. 7 ) and rapid-onset seizure-induced death ( Fig. 3 ). To establish a direct link between CD8 1 T cells and CNS myelomonocytic cell recruitment, we infected mice with LCMV and administered anti-CD8 antibody at days 4 and 5 post-infection-after CTL priming. This treatment, which reduced the number of CD8 1 T cells in the CNS by 94%, prevented the rapid onset of seizures at day 6 post-infection (data not shown), and significantly reduced the number of monocytes and neutrophils in the CNS ( Supplementary  Fig. 10 ). These data indicate that virus-specific CTLs can contribute to the recruitment of pathogenic myelomonocytic cells either by directly releasing chemoattractants or possibly by inducing other cells to release chemoattractants.
The requirement for CD8 1 T cells in the pathogenesis of LCMV meningitis led to the proposal that CTLs are directly responsible for tissue injury and death 17 . We propose that CTL activation through transient interactions with infected cells leads to massive recruitment of myelomonocytic cells, which compromise vascular integrity and initiate fatal convulsive seizures 3 . It is likely that once seizure-induced death is averted, infected mice ultimately succumb to another pathogenic mechanism possibly mediated by CTLs 18 . LETTERS It is well established that neutrophil extravasation can be linked to vascular leakage [19] [20] [21] , and this process usually depends on signalling between leukocytes and endothelial cells 22 . Neutrophil extravasation causes tissue injury in many models including reperfusion injury and sepsis 23, 24 . Using TPM we directly visualized this classical process in LCMV meningitis. Monocytes have been associated with atherosclerosis 25 and facilitation of the trafficking of neutrophils 26 . Our results suggest that monocytes also contribute vascular leakage, possibly through a mechanism linked to adherence to the blood vessels 27 and/or chemokine release 28 . Recognizing the complementary pathogenic functions of neutrophils and monocytes is critical for devising therapeutic approaches in CD8 1 T-cell-mediated pathology.
It is not clear why CD8 1 T cells recruit myelomonocytic cells to a site of viral infection. CD4 1 Th17 cells produce interleukin (IL)-17 to coordinate neutrophil recruitment, but anti-viral CD8 1 T cells express transcription factors that suppress this program 29 , and we observed no IL-17 production by peptide-stimulated P14 cells (data not shown). Therapies directed at reducing myelomonocytic activation are obvious treatment candidates to prevent the mode of immunopathology we observed, but are challenging because of their numerous effector mechanisms, fast turnover and acute importance in host defence. A more tractable approach might be to target the chemotactic mechanisms used by CTLs to attract myelomonocytic cells, or, alternatively, to enhance CTL-mediated killing of relevant targets by improving immunological synapse formation or stability 30 . The latter approach might break the feedback to the pathogenic myelomonocytic arm and improve survival as well as immunity in viral infections of the CNS.
METHODS SUMMARY
To induce meningitis, mice were infected intracerebrally with the Armstrong strain of LCMV. Immune cells were imaged through a surgically thinned skull using a Bio-Rad multi-photon microscope. Meningeal vasculature was visualized by intravenously injecting quantum dots 10 min before imaging. All imaging data were processed and analysed using Volocity software.
For flow cytometric studies, mice received an intracardiac perfusion with saline. The CNS was then harvested, treated with collagenase D, and mononuclear cells were isolated using a Percoll gradient. Afterwards, mononuclear cells were stained with fluorescently labelled antibodies, and acquired using a Becton Dickinson digital flow cytometer. Data were analysed using FlowJo software.
Low-dose (125 mg) anti-Gr-1 antibody (RB6-8C5 clone) was injected once at day 4 post-infection to deplete neutrophils only, whereas high-dose antibody (400 mg) was injected daily starting at day 3 post-infection to deplete both monocytes and neutrophils. CD8 1 T cells were depleted by injecting 1,000 mg of anti-CD8 (53-6.72 clone) on day 4 and 500 mg on day 5 post-LCMV infection.
CNS vascular leakage was evaluated by retroorbitally injecting mice with Evans blue. After 4 h, mice were perfused with saline, and brains were collected. Evans blue was extracted using N,N-dimethyl formamide and quantified using a Varioskan Flash fluorometer (620 nm excitation; 695 nm emission). Fluorescence images on vibratome brain sections were captured using a confocal microscope (637 nm excitation). All immunohistochemistry was performed as described in Methods.
To quantify gene expression changes in the LCMV-infected CNS, total RNA was isolated from saline perfused mock-and day 6 LCMV-infected brains and In neutrophil-depleted LysM-GFP mice, perivascular myelomonocytic cells were associated with transient quantum dot leakage (n). p-r, Representative three-dimensional reconstructions of two-photon z-stacks depicting skull bone (blue), quantum dot (red) and LysM-GFP 1 myelomonocytic cells (green) are shown for an asymptomatic mouse at day 5 (p), a symptomatic LysM-GFP mouse at day 6 (q), and a symptomatic LysM-GFP mouse at day 6 depleted of neutrophils (r). At day 5, vasculature showed smooth borders, no quantum dot (red) leakage and few LysM-GFP 1 cells (green). In symptomatic mice at day 6, LysM-GFP 1 cells were mostly observed extravasating from meningeal vasculature with some cells accompanying the vascular leakage down into the parenchyma (white arrow). In mice depleted of neutrophils (2PMN), LysM-GFP cells were observed in perivascular meningeal spaces. Grid scale for panels p-r is 19.7 mm. See corresponding Supplementary Movies 4 and 5.
hybridized to Mouse Exon 1.0 ST Arrays. The analysis was run using XRAY (version 2.3) software; the Excel add-in was from Biotique Systems Inc. Myelomonocytic cell chemoattractants with increased expression at day 6 post-infection were identified, and their expression at the protein level by P14 CTLs was quantified flow cytometrically.
METHODS
Transgenic mice. C57BL/6 (B6), B6 GFP 1 D b GP 33-41 TCR-transgenic (tg) (GFP 1 P14) 31 , B6 Thy1.1 1 D b GP [33] [34] [35] [36] [37] [38] [39] [40] [41] TCR-tg (Thy1.1 1 P14), B6 OT-I TCRtg, B6 perforin 2/2 (Prf1 2/2 ), B6 Tnf 2/2 , and B6 Ifngr 2/2 mice were bred and maintained in a closed breeding facility at The Scripps Research Institute. B6, B6 Ccr2 2/2 and B6 Fas 2/2 mice were obtained from The Jackson Laboratories. The following mice were gifts from other investigators: B6 LysM-GFP heterozygous knock-in mice (LysM gfp/1 ; T. Graf) 32 , B6 Jinx mice (B. Beutler) 33 , and 129 granzyme a 3 b cluster knockout mice (deficient in granzymes a, b, c and f; T. Ley) 34 . All mice were housed in specific-pathogen-free conditions and treated in accordance with Institutional Animal Care and Use Committee protocols of The Scripps Research Institute and New York University School of Medicine. Virus. To induce meningitis, adult mice at 6-8 weeks of age were infected intracerebrally (i.c.) with 1 3 10 3 plaque-forming units of LCMV Armstrong clone 53b. Survival was monitored daily. Stocks were prepared by a single passage on BHK-21 cells, and viral titres were determined by plaque formation on Vero cells. Mononuclear cell isolations and tissue processing. To obtain cell suspensions for flow cytometric analysis, the brain and spinal cord were harvested from mice after an intracardiac perfusion with 25 ml of 0.9% saline solution to remove the contaminating blood lymphocytes. The CNS was then incubated with 1 ml collagenase D (1 mg ml 21 ; Roche) at 37 uC for 30 min. Single-cell suspensions were prepared by mechanical disruption through a 100-mm filter. Brain-infiltrating leukocytes were isolated and counted as described previously 35 . For immunohistochemical analyses, fresh, unfixed brain tissue was either frozen on dry ice in optimal cutting temperature compound (OCT, Tissue-Tek, for frozen sectioning) or incubated overnight (,15 h) with 4% paraformaldehyde (PFA, for vibratome sectioning). GFP 1 P14 cell transfer. CD8 1 T cells were purified from GFP 1 P14 mouse splenocytes by negative selection (Stem Cell Technologies). The purity after enrichment was determined to be greater than 98%. For imaging studies, 1 3 10 5 purified GFP 1 P14 CD8 1 T cells were injected i.v. into naive mice. One day later the mice were challenged i.c. with LCMV Armstrong. OT-I cell transfer. Splenocyes were isolated from OT-I mice and expanded in vitro for 7 days in RPMI 1640 containing 10% FBS, 1%L-glutamine, 1% penicillin/ streptomycin, 500 units ml 21 IL-2, and 1 mg ml 21 ovalbumin (OVA) [257] [258] [259] [260] [261] [262] [263] [264] (SIINFEKL) peptide. The cells were then labelled with 5 mM CFSE in PBS (Invitrogen) at 37 uC for 5 min and washed three times in PBS. 1 3 10 7 CFSElabelled OT-I cells were transferred into each day 6 LCMV-infected B6 mouse, and intravital imaging was performed 6-12 h after the transfer.
CD8 T-cell depletion. To deplete CD8 1 T cells from LCMV-infected B6 mice, 1,000 mg of purified, endotoxin-free anti-CD8 (53-6.72 clone) was injected on day 4 and 500 mg was injected on day 5 post-LCMV infection. This resulted in a 94% reduction in CNS-infiltrating CD8 1 T cells. The control group for these experiments was injected with polyclonal rat IgG (Jackson ImmunoResearch Laboratories). Neutrophil depletion. To deplete myelomonocytic cells from B6 and B6 Ccr2 2/2 mice, 125 mg (low dose) or 400 mg (high dose) of purified, endotoxin-free anti-Gr-1 (RB6-8C5 clone) antibody was injected intraperitoneally. The RB6-85C hybridoma was provided by P. Allen. Low-dose antibody was injected once at day 4 post-infection to deplete neutrophils only. This resulted in an 87% reduction of neutrophils in the CNS and 98% reduction in the blood. High-dose antibody was injected daily starting at day 3 post-infection to deplete both neutrophils and monocytes. Injection of polyclonal rat IgG (Jackson ImmunoResearch Laboratories) was used as a control. Gene array. Total RNA from mock-and day 6 LCMV-infected brains (n 5 3 mice per group) was isolated using a Qiagen RNeasy Midi prep kit and then quantified using Nanodrop ND-1000. Sample quality was checked using an Agilent 2100 Bioanalyser. To remove most of the ribosomal RNA from the RNA, 2.5 mg of each sample was taken through RiboMinus (Invitrogen). After RiboMinus treatment, samples were amplified and labelled using the GeneChip whole-transcript sense target labelling assay (Affymetrix). Samples were checked by gel-shift assay to assess labelling efficiency as described in the GeneChip whole-transcript sense target labelling assay manual. Samples were hybridized overnight to the Mouse Exon 1.0 ST Array. Hybridization and scanning of samples to arrays was performed using standard Affymetrix protocols and reagents from the GeneChip hybridization, wash and stain kit. Chips were scanned using the Affymetrix GeneChip Scanner 3000 7G with default settings. To identify genes with differential gene expression or alternative splicing between the two groups, we studied three hybridizations each on the Mouse Exon 1.0 ST array using mixed model ANOVA. The analysis was run using XRAY (version 2.3) software, with the Excel add-in from Biotique Systems Inc. Analysis of BBB integrity. To quantify BBB permeability, Evans blue leakage in the brains of mock-infected or LCMV i.c. infected mice was assessed. On the indicated day, mice were injected retroorbitally with 20 mg Evans blue per kg body weight (Sigma). After 4 h, the brains were extracted after a PBS perfusion, which was used to eliminate circulating Evans blue. The tissue was homogenized in 600 ml of N,N-dimethyl formamide (Sigma). The homogenate was transferred to new tubes, centrifuged at 16,000g for 20 min at 4 uC and the supernatant was plated in triplicate wells in a 96-well flat-bottom plate. For quantification, an Evans blue standard was diluted in the supernatant of a PBS-perfused uninfected brain that received no Evans blue, but was homogenized in N,N-dimethyl formamide. All samples plated in triplicate were read using a Varioskan Flash fluorometer (620 nm excitation; 695 nm emission; Thermo Scientific). The excitation and emission wavelengths were determined by spectral scanning to be optimal for Evans blue. Representative qualitative images of Evans blue permeability from PBS perfused brains were taken using a digital camera. Flow cytometry. Brain-infiltrating leukocytes were collected and blocked with 3.3 mg ml 21 anti-mouse CD16/CD32 (Fc block; BD Biosciences) in PBS containing 1% FBS and 0.1% sodium azide for 15 min on ice. After Fc block, cells were stained with the following conjugated antibodies: CD45.2 fluorescein isothiocyanate (FITC) (104), Thy1.2 phycoerythrin (PE) (53-2.1), CD19 peridininchlorophyll-protein complex (PerCP) cyanin (CY)5.5 (1D3), Gr-1 allophycocyanin (APC) (RB6-8C5), CD4 APC Cy7 (GK1.5; BD Biosciences), CD8 Pacific Blue (Caltag), MCA771 PE (7/4; Serotec), and anti-CD11b PE/Cy7 (M1/70; eBioscience). Cells were acquired using a digital flow cytometer (Digital LSR II; Becton Dickinson) and flow cytometric data were analysed with FlowJo software (Tree Star, Inc.). Intracellular chemokine staining. Mice seeded with 10 4 P14 Thy1.1 cells on day 21 were infected with 10 3 plaque-forming units of LCMV Armstrong i.c. on day 0. On day 6 post-infection, brain-infiltrating leukocytes and splenocytes from infected mice and splenocytes from naive P14 Thy1.1 mice were collected and stimulated with 50 U ml 21 IL-2 (Roche), 1 mg ml 21 brefeldin A (Sigma-Aldrich) and 1 mg ml 21 GP 33-41 peptide for 5 h at 37 uC. Cells were centrifuged and then blocked with 3.3 mg ml 21 anti-mouse CD16/CD32 (Fc block; BD Biosciences) in PBS containing 1% FBS and 0.1% sodium azide for 15 min on ice. After Fc block, cells were stained with the following conjugated antibodies: CD45.2 FITC (104), Thy1.1 PerCP (53-2.1; BD Biosciences) and CD8 APC/Cy7 (53-6.7; BioLegend) for 30 min on ice. Cells were washed and fixed for 10 min at room temperature (,26 uC) in PBS containing 1% FBS, 0.1% sodium azide, 1% PFA and 0.1% saponin. Intracellular staining and washes for all intracellular steps were conducted in PBS containing 1% FBS, 0.1% sodium azide and 0.1% saponin. Cells were stained with PE-conjugated antibodies against CCL-2 (1:100, BioLegend) and CCL3 (1:100, R&D Systems), biotinylated antibodies against CCL5 and CXCL2 (1:100, R&D Systems) or purified antibodies against CCL4 (1:200, BD Bioscience) and CCL7 (1:100, R&D Systems) for 30 min on ice. Secondary and tertiary incubations with biotinylated anti-rat IgG1 (1:100, BioLegend), PE-conjugated donkey anti-goat (1:100, Jackson Immunoresearch Laboratories) or SA-APC (1:100, Invitrogen) were used in subsequent steps. After the final wash, cells were resuspended in PBS containing in 1% FBS and 0.1% sodium azide and acquired using a digital flow cytometer. Immunohistochemistry. To examine LCMV localization, 6-mm frozen sections were cut, fixed with 4% PFA for 15 min, blocked with an avidin/biotin-blocking kit (Vector Laboratories), and stained for 1 h at room temperature with primary guinea pig antibodies against LCMV (1:500). Secondary and tertiary incubations with biotinylated donkey anti-guinea pig (1:200; Jackson ImmunoResearch Laboratories) and streptavidin Rhod-X (1:250; Jackson ImmunoResearch Laboratories), respectively, were performed to detect LCMV antigen. Co-labelling of fibroblasts (anti-ER-TR7; 1:100; Abcam), astrocytes (anti-GFAP; 1:800, DakoCytomation), infiltrates (anti-CD45.2; 1:100, BD Biosciences), endothelium (anti-CD31; 1:200; Chemicon) or smooth muscle actin (anti-SMA; 1:100; Abcam) was also conducted in conjunction with anti-LCMV staining. The cell-markerspecific antibodies were detected with secondary antibodies conjugated to FITC (1:200; Jackson ImmunoResearch Laboratories). All working stocks of primary and secondary reagents were diluted in PBS containing 2% fetal bovine serum (FBS). To generate three-dimensional renderings of LCMV-infected fibroblasts, 100-mm vibratome sections were cut using a Leica VT1000S (Leica) and blocked with PBS containing 10% FBS and 0.1% saponin for 1 h at room temperature. Staining for LCMV and fibroblasts was conducted as indicated above, with the exception that the antibodies were diluted in PBS containing 2% FBS supplemented with 0.1% saponin. To obtain images of Evans blue leakage, 100-mm vibratome sections from PBS-perfused mice injected with Evans blue (as described previously) were stained with anti-CD31 (1:200; Chemicon) diluted in PBS containing 2% FBS supplemented with 0.5% Triton-X (Sigma-Aldrich). CD31 was detected and amplified with a FITC-conjugated goat anti-hamster antibody (1:200; Jackson ImmunoResearch Laboratories), a rabbit anti-FITC antibody (1:200; Zymed) and a FITC-conjugated anti-rabbit antibody (1:200; Jackson ImmunoResearch Laboratories). All sections described above were further stained
